Wendy London Discusses Adaptive Neuroblastoma Risk Groups in LMICs – Resonance

Wendy London Discusses Adaptive Neuroblastoma Risk Groups in LMICs – Resonance

Resonance shared a post on LinkedIn:

“This Thursday: Join us in the Global Neuroblastoma Network, 22 January 2026 (0830EST), as we welcome Wendy London of Boston Children’s Hospital.

Dr. London will share on the recent publication: ‘Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project’.

We look forward to learning more about this important work together this Thursday.

See you there.

Join us!”

Wendy London

More posts from Resonance on OncoDaily.